Wegovy (Semaglutide)

Prescription-only medicine Once-weekly injection Weight management

£140.00 (Weekly Injection)


Wegovy contains semaglutide, a prescription medicine used for weight management alongside a reduced-calorie diet and increased physical activity.

It acts on the body's appetite-regulating system to help reduce hunger and food intake. Treatment is prescribed following a clinical assessment to establish whether it is suitable for you.

  • Active ingredient: Semaglutide
  • Available strengths: 0.25 mg to 2.4 mg
  • Administration: Once-weekly injection
  • Prescription required: Yes
Book your consultation
Description

Wegovy is a prescription injection containing semaglutide, a medicine used to manage weight in eligible patients.

For adults, it is licensed for those with a BMI of 30 or above, or 27 or above with at least one weight-related health condition.

It is used alongside a reduced-calorie diet and increased physical activity.

Wegovy is also licensed for certain adolescents aged 12 and above who meet specific clinical criteria.

Wegovy mimics glucagon-like peptide-1 (GLP-1), a hormone involved in regulating appetite and food intake.

It acts on appetite-related pathways in the brain, helping reduce hunger and increase feelings of fullness. This may support weight reduction when combined with dietary changes and regular physical activity.

Some people notice reduced hunger during the early weeks of treatment, but weight-loss results develop gradually and vary between individuals.

The dosage is usually increased over 16 weeks to improve tolerability. Your healthcare professional will monitor progress and assess whether continuing treatment is appropriate.

Warnings

Wegovy must not be used by anyone allergic to semaglutide or another ingredient in the medicine.

It should not be used during pregnancy or breastfeeding. Before treatment, inform your prescriber if you have:

  • A history of pancreatitis.
  • Severe gastrointestinal problems.
  • Kidney problems or dehydration.
  • Diabetes or diabetic retinopathy.
  • Any planned surgery involving anaesthesia or deep sedation.

Important Precautions:

Wegovy should be stopped at least two months before a planned pregnancy.

Tell your prescriber about all other medicines you use, particularly insulin, sulphonylureas or other medicines that affect blood sugar levels.

Directions

Wegovy is injected under the skin once weekly, usually into the abdomen, thigh or upper arm.

Treatment normally begins at 0.25 mg once weekly. The dose is increased gradually, typically every four weeks, to a maintenance dose of 2.4 mg.

A higher 7.2 mg weekly maintenance dose may be prescribed for certain adults with obesity when clinically appropriate.

Important Usage Instructions:

  • Inject on the same day each week.
  • Rotate injection sites to avoid irritation.
  • Follow the instructions supplied with your prescribed pen.
  • Never change your dose without medical advice.
  • Follow the patient leaflet if you miss a dose.
Ingredients

Active Ingredient:

Semaglutide, supplied in different strengths depending on the prescribed treatment stage.

Other Ingredients:

Wegovy FlexTouch contains disodium phosphate dihydrate, propylene glycol, phenol, hydrochloric acid and sodium hydroxide (used to adjust acidity), and water for injections.

Always check the packaging and patient information leaflet for the complete formulation, as ingredients may differ between presentations.

Side Effects

Common Side Effects:

  • Nausea or vomiting.
  • Diarrhoea or constipation.
  • Abdominal pain or bloating.
  • Headaches.
  • Feeling tired or dizzy.

Digestive side effects are particularly common during dose increases and may improve as the body adjusts.

Serious Side Effects:

Less common but serious problems include pancreatitis, gallbladder problems, severe allergic reactions and dehydration.

A rare eye condition affecting the optic nerve has also been reported with semaglutide.

Seek urgent medical attention if you experience severe, persistent abdominal pain, sudden loss of vision, difficulty breathing or facial swelling.

A pharmacist in consultation with a patient

Not Sure Where to Start? We're Here to Help!

Understanding which treatment is right for you and how much it will cost you is an important part of your weight loss journey. If you're unsure about eligibility, dosage, and pricing, we're here to help you!

Book your consultation - an in-person consultation with our expert team where you'll receive personalised advice.

Book An Appointment

Frequently Asked Questions

How does Wegovy help with weight loss?

Wegovy contains semaglutide, which mimics the GLP-1 hormone that regulates appetite. It helps you feel fuller for longer and reduces hunger, so you eat less alongside a reduced-calorie diet and more physical activity.

Who is eligible for Wegovy?

Adults with a BMI of 30 or above, or 27 or above with at least one weight-related health condition, following a clinical assessment at the pharmacy.

How is Wegovy taken?

As a once-weekly injection under the skin of the abdomen, thigh or upper arm, on the same day each week. Treatment starts at 0.25 mg and is increased gradually, usually every four weeks, to a maintenance dose of 2.4 mg.

What are the most common side effects?

Nausea, diarrhoea or constipation, abdominal pain, headaches and tiredness are the most common, particularly when the dose is increased. They usually ease as your body adjusts.

Can I use Wegovy if I am pregnant or planning a pregnancy?

No. Wegovy should not be used during pregnancy or breastfeeding, and should be stopped at least two months before a planned pregnancy.

Do I need a prescription?

Yes. Wegovy is a prescription-only medicine. Book a consultation and our pharmacist will assess whether it is suitable for you.